Our healthcare system is irretrievably broken, and now is devastating the US financially. Pharmocracy II, like its predecessor Pharmocracy, uncovers egregious FDA incompetence, abuse, and corruption. It shows how over-regulation causes lifesaving medications to be delayed or suppressed altogether, while approving vastly expensive, minimally effective, and often dangerous drugs. Faloon lays out a completely different approach to healthcare, one that would greatly improve American health while also rescuing the economy.
Our healthcare system is irretrievably broken, and now is devastating the US financially. Pharmocracy II, like its predecessor Pharmocracy, uncovers egregious FDA incompetence, abuse, and corruption. It shows how over-regulation causes lifesaving medications to be delayed or suppressed altogether, while approving vastly expensive, minimally effective, and often dangerous drugs. Faloon lays out a completely different approach to healthcare, one that would greatly improve American health while also rescuing the economy.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Preface Introduction Preamble The FDA: Failure to Protect FDA Suffers Major Legal Defeat in Court (2016) CoQ10 Wars (2015) Horrific Conditions inside Drug Factories (2013) Metformin Makes Headline News (2012) Big Pharma: Putting Profits above Patients New England Journal of Medicine Exposes Generic Price Scandal (2016) Unsustainable Cancer Drug Prices (2014) Legal Murder (2012) A Tragic Miscarriage of Justice (2012) Healthcare Crisis: Can the System Survive? Collapsing Within Itself (2014) Former FDA Commissioner Admits Risk of Bureaucratic Delay (2012) How Regulation of Medicine is Bankrupting the United States (2011) Cancer: Is the "Standard of Care" the Best Treatment? Stay Informed! Assembly Line Medicine (2014) Intolerable Delays (2014) Bureaucratic Assault on New Cancer Therapies (2011) Cancer Establishment Hides Radiation Side Effects (2011) Taking Action Unsustainable High Drug Prices (2017)
Preface Introduction Preamble The FDA: Failure to Protect FDA Suffers Major Legal Defeat in Court (2016) CoQ10 Wars (2015) Horrific Conditions inside Drug Factories (2013) Metformin Makes Headline News (2012) Big Pharma: Putting Profits above Patients New England Journal of Medicine Exposes Generic Price Scandal (2016) Unsustainable Cancer Drug Prices (2014) Legal Murder (2012) A Tragic Miscarriage of Justice (2012) Healthcare Crisis: Can the System Survive? Collapsing Within Itself (2014) Former FDA Commissioner Admits Risk of Bureaucratic Delay (2012) How Regulation of Medicine is Bankrupting the United States (2011) Cancer: Is the "Standard of Care" the Best Treatment? Stay Informed! Assembly Line Medicine (2014) Intolerable Delays (2014) Bureaucratic Assault on New Cancer Therapies (2011) Cancer Establishment Hides Radiation Side Effects (2011) Taking Action Unsustainable High Drug Prices (2017)
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826